Author: healthadmin

Bedfont® Scientific Limited, an innovative MedTech company specializing in the design and manufacture of medical breath analyzers, is thrilled to have been shortlisted in the Export Performance category of the Science and Engineering Health Technologies Alliance (SEHTA) Healthcare Business Awards 2026. The SEHTA Healthcare Business Awards are one of the Southeast’s leading healthcare innovation awards, celebrating excellence in healthcare, particularly life sciences and medical technology. Bedfont® is a world leader in breath analysis and has experienced significant growth over the past decade, with a strong focus on international sales, with over 59% of export sales contributing to annual sales. Being…

Read More

An early warning system for sepsis, one of the deadliest infections for hospitalized patients, has been approved for use by the FDA, making it one of the first AI-based medical tools to receive clearance. The tool, developed by researchers at Johns Hopkins University and now commercialized by Bayesian Health, detects sepsis hours earlier than doctors and reduces deaths by almost 20%. “Pre-suspect screening is what creates lead time, and lead time is what changes sepsis outcomes. Once a clinician already suspects sepsis, the clock continues to tick, often for hours and even days,” says lead researcher Suchi Sarria. He is…

Read More

Enterprise Therapeutics Ltd. (Enterprise), a biopharmaceutical company dedicated to discovering and developing new treatments to improve the lives of people with respiratory diseases, today announced that a Phase 2 study of ETD001, the company’s lead candidate for the treatment of cystic fibrosis (CF), achieved key efficacy results. This study aimed to investigate the efficacy, safety, tolerability, and pharmacokinetics of inhaled ETD001 in the 10% of patients with CF (pwCF) who do not benefit from treatment with CFTR modulators and have the highest unmet medical need. Data from this trial showed improved lung function over 28 days compared to placebo. ETD001…

Read More

Recent research published in Journal of Experimental Politics This suggests that threatening men’s sense of masculinity may not lead them to adopt more conservative or typically masculine political beliefs. Researchers tested thousands of participants across the United States and found no consistent evidence that making men feel insecure about their gender identity changes their political attitudes. In both popular culture and politics, many commentators argue that society is facing a crisis of masculinity. Some politicians have made this idea central to their campaign platforms, suggesting that traditional masculinity is under attack. Sociologists and psychologists often attribute the rise in far-right…

Read More

Bicara Therapeutics prepares to accelerate cancer drug approvals next year, with the biotechnology company appointing Chris Sarchi as chief commercial officer. Mr. Sarchi joins Bicara after three and a half years at cancer drug maker Replimune. Just last month, the company laid off hundreds of employees after the FDA rejected its melanoma drug. Prior to that, he spent five years at French pharmaceutical giant Sanofi in oncology and transplant roles in the United States, and five years at German pharmaceutical company Boehringer Ingelheim. Mr. Sarchi joins Vicara at a pivotal time in Vicara’s history. In 2024, the company raised $362…

Read More

Their long necks, huge bodies, small heads, and flared tails make sauropods one of the most famous dinosaurs ever discovered. These plant-eating giants include some of the largest land animals in Earth’s history, with some species reaching nearly 130 feet (40 meters) in length. Famous examples include Diplodocus and Brachiosaurus. Now, researchers studying fossils from southern Argentina have identified a new member of this iconic group. dinosaurs named Vicaracosaurus dionydeiwas smaller than the largest sauropods, but still had an estimated length of 65 feet (20 meters). Giant dinosaur fossil discovered in Patagonia Scientists recovered part of the dinosaur’s spine, including…

Read More

Researchers at Osaka University discovered that the zinc finger proteins RLF and ZFP292 help stabilize the CoREST corepressor complex at gene promoters in embryonic stem cells, preventing differentiation. Stem cells are the cell type from which all other cells and tissues in the body originate, and they do so through a very tightly controlled process. However, it remains unclear how stem cells differentiate in addition to gene control systems such as canonical REST silencing that prevent gene expression in inappropriate tissues.Now, Japanese researchers have discovered an overlapping two-factor system that plays a key role in controlling how and when these…

Read More

Recent research published in Proceedings of the National Academy of Sciences A new drug developed using artificial intelligence suggests that it can significantly reduce fentanyl consumption in animal models. This experimental drug targets specific serotonin receptors in the brain, restoring neural pathways altered by addiction. These findings provide evidence that this new compound may ultimately provide a non-addictive treatment option for people experiencing opioid use disorder. Opioid use disorder currently affects millions of people, and synthetic opioids like fentanyl are creating a serious public health crisis. In search of alternative treatments, scientists have focused on developing treatments that address the…

Read More

A new AI framework called MOZAIC can help doctors more accurately match fecal transplant donors and recipients and increase treatment success by predicting how the gut microbiome will converge after treatment. Research: Matching donor and recipient gut microbiota with artificial intelligence for optimized fecal microbiota transplantation. Image credit: Life Sciences/Shutterstock.com recent cell reports In this study, we investigated whether donor and recipient gut microbiomes utilizing AI consistent with the MOZAIC framework can improve the clinical efficacy of fecal microbiota transplantation (FMT) by optimizing microbiome convergence after FMT and predicting patient outcomes. Challenges and determinants of FMT effectiveness Fecal microbiota transplantation…

Read More